Yu‐Chiau Shyu
Biographic Data
| ID | 7930516 |
|---|---|
| NAME | Yu‐Chiau Shyu |
| GIVEN NAMES | Yu‐Chiau |
| FAMILY NAME | Shyu |
| SIGNATURE | SHYU Y C |
| AFFILIATIONS | Chang Gung University of Science and Technology |
| ORCID | 0000-0003-1747-2226 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Comorbidity of Narcolepsy and Psychotic Disorders
This nationwide study revealed that narcolepsy and psychotic disorders commonly co-occur. Pharmacotherapy for narcolepsy was not associated with the risk of psychotic disorders. Our findings serve as a reminder that clinicians must consider the comorbidity of narcolepsy and psychosis
Attention-Deficit/Hyperactivity Disorder, Its Pharmacotherapy, and Adrenal Gland Dysfunction
This study aims to examine the co-occurrence rate of attention deficit hyperactivity disorder (ADHD) and adrenal gland disorders, as well as whether pharmacotherapy may affect ADHD patients' risk of developing adrenal gland disorder. One group of patients newly diagnosed with ADHD ( n = 75,247) and one group of age- and gender-matching controls ( n = 75,247) were chosen from Taiwan's National Health Insurance database during the period of January…
No prominent works on this page.
Comorbidity of Narcolepsy and Psychotic Disorders
This nationwide study revealed that narcolepsy and psychotic disorders commonly co-occur. Pharmacotherapy for narcolepsy was not associated with the risk of psychotic disorders. Our findings serve as a reminder that clinicians must consider the comorbidity of narcolepsy and psychosis
Attention-Deficit/Hyperactivity Disorder, Its Pharmacotherapy, and Adrenal Gland Dysfunction
This study aims to examine the co-occurrence rate of attention deficit hyperactivity disorder (ADHD) and adrenal gland disorders, as well as whether pharmacotherapy may affect ADHD patients' risk of developing adrenal gland disorder. One group of patients newly diagnosed with ADHD ( n = 75,247) and one group of age- and gender-matching controls ( n = 75,247) were chosen from Taiwan's National Health Insurance database during the period of January…
Medicine (2 works) · Population (2 works) · Psychiatry (2 works) · Adrenal gland (1 works) · Atomoxetine (1 works) · Attention Deficit Hyperactivity Disorder (1 works) · Comorbidity (1 works) · Endocrinology (1 works) · Environmental health (1 works) · Functional Brain Connectivity Studies (1 works)